News
Chronic hepatitis B treatment relies on nucleoside or nucleotide analogue drugs that suppress hepatitis B virus (HBV) ...
iDepartment of Molecular Microbiology and Immunology, Saint Louis University School of Medicine, Saint Louis, MO, USA jSaint Louis University Institute for Drug and Biotherapeutic Innovation, Saint ...
A scleroderma patient in a Sylvester Comprehensive Cancer Center trial was recently successfully treated with CAR T-cell lymphoma therapy, in what researchers are calling an “immunological reset.” ...
A team of Memorial Sloan Kettering Cancer Center (MSK) researchers have made an important finding about why genetically ...
Sail Biomedicines is shrinking its crew for the second time this year. | Sail Biomedicines is shrinking its crew for the ...
CLL can mean fatigue, fear and years of waiting but new research shows that staying active helps people feel better – and ...
While Novartis holds a diversified product portfolio, there is some product concentration with its largest drugs, Entresto (close to 15% of sales) and Cosentyx (close to 10% of sales). Both drugs will ...
This study provides valuable findings regarding potential correlates of protection against the African swine fever virus. The evidence supporting the claims is solid, although analysis using a higher ...
Immune checkpoint blockade (ICB) therapies have revolutionized cancer treatment, yet many tumors remain resistant. Now, ...
UC Davis researchers find cats could help us learn about long COVID. They've found a new cell therapy boosts immune systems in cats with severe coronavirus.
At the surface, the immune response to a flu virus is simple. Some cells recognize the pathogen and send a signal to the ...
In a study published in the journal Immunity, Fran Lund, Ph.D., professor of microbiology and director of the University of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results